x SCICLONE

  • ANNUNCIO: Segui le NewsLetter di Borse.it.

    Al via la Newsletter di Borse, con tutte le notizie quotidiane sui mercati finanziari. Iscriviti per rimanere aggiornato con le ultime News di settore, quotazioni e titoli del momento.
    Per iscriverti visita questo link.

Sisono ricoperti di brutto!

Ciao tremaui,ti ringrazio per la stupenda videata!Io questi mezzi me li sogno!! Cmq vedo che si sono ricoperti questi hedge f. Il motivo nn lo sò penso dovute a scadenze tecniche! O a news nel fine settimana spero belle!bye e grazie!:)
 
Grafici!!

Tremaui vedo che su alcuni siti americani i pezzi finali del titolo sono diversi!! Sù yahoo.com il grafico indica finale ultimi 30 secondi con circa 250.000pz invece nasdaq.com e cbs.market indica solo 70mila pz finali.Come mai?
 
Re: Grafici!!

Scritto da sciclone
Tremaui vedo che su alcuni siti americani i pezzi finali del titolo sono diversi!! Sù yahoo.com il grafico indica finale ultimi 30 secondi con circa 250.000pz invece nasdaq.com e cbs.market indica solo 70mila pz finali.Come mai?
bah non saprei non sono mai attendibili dipende da chi prendono i dati molto probabilmente....:)
 
altri 60mila pz

Adesso i totali sono 610mila.Vedremo lunedì!Grazie ancora.bye
 
solitamente non rimangono mai sui bordi;) :D
 
close piatta!

Close piatta vicino a 7$.Il supporto a 6,6 sembra superato ora ci avviciniamo a 7,3.Quindi dopo finale di venerdì scoppiettante oggi seduta fiacca di riflessione!;) bye
 
non farti trarre in inganno....;) ;) entrato a 6.88$
 
SciClone Pharmaceuticals, Inc.

NASDAQ: SCLN - $7.70

Rating: Buy

FYE Dec 2002A 2003E 2004E

Market Cap ($MM) $342 EPS ($0.29) ($0.12) ($0.27)

Float (MM) 35.7 P/E Nm Nm Nm

12-Month Price Target $13

We reiterate our Buy rating and $13 target price. Yesterday, SciClone
reported 3Q03 loss per share of $0.07, $0.03 better than our loss per share
estimate of $0.10.

Zadaxin revenue of $5.4 million (up 26% YoY) exceeded our $5.1 million
estimate by 5%.

As expected, 3Q03 Zadaxin sales returned to levels consistent with
historical trends after the significant, temporary increase related to the
SARS epidemic in China in 2Q03.

At the AASLD conference in Boston, SciClone presented promising interim
results of a pilot trial evaluating Zadaxin in combination with PEG-IFN and
ribavirin in HCV non-responders.
 
Scritto da tremaui
SciClone Pharmaceuticals, Inc.

NASDAQ: SCLN - $7.70

Rating: Buy

FYE Dec 2002A 2003E 2004E

Market Cap ($MM) $342 EPS ($0.29) ($0.12) ($0.27)

Float (MM) 35.7 P/E Nm Nm Nm

12-Month Price Target $13

We reiterate our Buy rating and $13 target price. Yesterday, SciClone
reported 3Q03 loss per share of $0.07, $0.03 better than our loss per share
estimate of $0.10.

Zadaxin revenue of $5.4 million (up 26% YoY) exceeded our $5.1 million
estimate by 5%.

As expected, 3Q03 Zadaxin sales returned to levels consistent with
historical trends after the significant, temporary increase related to the
SARS epidemic in China in 2Q03.

At the AASLD conference in Boston, SciClone presented promising interim
results of a pilot trial evaluating Zadaxin in combination with PEG-IFN and
ribavirin in HCV non-responders.
Grazie tremaui!Vedremo quante azioni ha in mano il caro jefferies!;)
 
Institution Shares Shares % Last
Held Changed Held Reported

BARCLAYS GLOBAL INVESTORS, 1,964,524 20,832 4.43
JEFFERIES & COMPANY, INC. 1,347,524 1,347,524 3.04
SECURITY MANAGEMENT COMP 1,153,846 0 2.60
VANGUARD GROUP, INC. 1,148,976 462,308 2.59
SMITH BARNEY ASSET MANAG 662,669 594,512 1.49
STATE STREET GLOBAL ADVISORS 656,165 390,800 1.48
FIDELITY MANAGEMENT & RESEA 600,000 585,464 1.35
DELAWARE INVESTMENT ADVISERS, 600,000 600,000 1.35
DIMENSIONAL FUND ADVISORS, INC 558,900 (46,100) 1.26
LEGG MASON WOOD WALKER, INC. 427,800 6,500 0.96
VEREDUS ASSET MANAGEMENT LLC 401,700 401,700 0.91
BANC OF AMERICA CAPITAL MANAGE 303,506 302,506 0.68
COLLEGE RETIREMENT EQUITIES FU 268,565 119,704 0.61
EMERALD ADVISERS, INC. 220,000 220,000 0.50
PERSEUS, L.L.C. 207,860 (200,000) 0.47
FRANKLIN PORTFOLIO ASSOCIATES, 191,500 145,200 0.43
RYDEX GLOBAL ADVISORS 188,750 188,750 0.43
MELLON PRIVATE WEALTH MANAG 169,233 19,192 0.38
NORTHERN TRUST INVESTMENTS, IN 164,041 95,850 0.37
FRANKLIN STREET ADVISORS, INC. 142,000 0 0.32
ARGUS PARTNERS, L.L.C. 140,000 140,000 0.32
MERRILL LYNCH INVESTMENT MANAG 136,500 (800) 0.31
SOMERVILLE TRADING ENTERPRISES 122,368 (38,402) 0.28
BATTERYMARCH FINANCIAL MANAG 117,724 117,724 0.27
CALIFORNIA STATE TEACHERS' RET 100,744 4,911 0.23
AMERICAN CENTURY INVESTMENT MG 86,420 85,905 0.19
FIRST STATE INVESTMENTS LTD (E 80,589 80,589 0.18
EATON VANCE MANAGEMENT, INC. 76,800 76,800 0.17
AMERICAN EXPRESS FINANCIAL ADV 71,160 260 0.16
KENWOOD CAPITAL MANAGEMENT, LL 70,900 0 0.16
PANGAEA, L.P. 68,100 68,100 0.15
OHIO PUBLIC EMPLOYEES RETIREME 64,819 0 0.15
NORTHERN TRUST GLOBAL INVESTME 56,100 18,400 0.13
DEERE & CO. 53,700 32,200 0.12
UBS FINANCIAL SERVICES INC. 51,450 27,600 0.12
BEDFORD OAK ADVISORS, L.L.C. 50,000 50,000 0.11
RENAISSANCE TECHNOLOGIES CORP. 48,975 48,975 0.11
DEUTSCHE ASSET MANAGEMENT AMER 44,798 (59,435) 0.10
STATE TEACHERS RETIREMENT SYST 42,600 42,600 0.10
PENNSYLVANIA PUBLIC SCHOOL EMP 41,100 41,100 0.09
JACOBS LEVY EQUITY MANAGEMENT, 40,500 (19,000) 0.09
DEUTSCHE BANK SECURITIES INC. 39,806 11,841 0.09
MORGAN STANLEY INVESTMENT MANA 36,031 5,348 0.08
BANC OF AMERICA SECURITIES LLC 34,500 (298,506) 0.08
DAVIS, SKAGGS INVESTMENT MANAG 33,400 33,400 0.08
ORIGIN CAPITAL MANAGEMENT LLC 30,000 30,000 0.07
FLORIDA STATE BOARD OF ADMINIS 27,884 (2,916) 0.06
NORTHERN TRUST COMPANY OF CONN 25,600 25,600 0.06
SG COWEN SECURITIES CORPORATIO 25,510 1,610 0.06
GEODE CAPITAL MANAGEMENT, L.L. 24,670 0 0.06


13F data provided by: Thomson Financial; 1-(800)-275-4376. Holdings by
institutions tabulated by Thomson Financial as of Nov. 20, 2003; represents
91% of total money managers filing with the SEC.
Copyright, Thomson Financial, 2003. All Rights Reserved.

(END) Dow Jones Newswires
12-05-03 0440ET
 
Scritto da tremaui
Institution Shares Shares % Last
Held Changed Held Reported

BARCLAYS GLOBAL INVESTORS, 1,964,524 20,832 4.43
JEFFERIES & COMPANY, INC. 1,347,524 1,347,524 3.04
SECURITY MANAGEMENT COMP 1,153,846 0 2.60
VANGUARD GROUP, INC. 1,148,976 462,308 2.59
SMITH BARNEY ASSET MANAG 662,669 594,512 1.49
STATE STREET GLOBAL ADVISORS 656,165 390,800 1.48
FIDELITY MANAGEMENT & RESEA 600,000 585,464 1.35
DELAWARE INVESTMENT ADVISERS, 600,000 600,000 1.35
DIMENSIONAL FUND ADVISORS, INC 558,900 (46,100) 1.26
LEGG MASON WOOD WALKER, INC. 427,800 6,500 0.96
VEREDUS ASSET MANAGEMENT LLC 401,700 401,700 0.91
BANC OF AMERICA CAPITAL MANAGE 303,506 302,506 0.68
COLLEGE RETIREMENT EQUITIES FU 268,565 119,704 0.61
EMERALD ADVISERS, INC. 220,000 220,000 0.50
PERSEUS, L.L.C. 207,860 (200,000) 0.47
FRANKLIN PORTFOLIO ASSOCIATES, 191,500 145,200 0.43
RYDEX GLOBAL ADVISORS 188,750 188,750 0.43
MELLON PRIVATE WEALTH MANAG 169,233 19,192 0.38
NORTHERN TRUST INVESTMENTS, IN 164,041 95,850 0.37
FRANKLIN STREET ADVISORS, INC. 142,000 0 0.32
ARGUS PARTNERS, L.L.C. 140,000 140,000 0.32
MERRILL LYNCH INVESTMENT MANAG 136,500 (800) 0.31
SOMERVILLE TRADING ENTERPRISES 122,368 (38,402) 0.28
BATTERYMARCH FINANCIAL MANAG 117,724 117,724 0.27
CALIFORNIA STATE TEACHERS' RET 100,744 4,911 0.23
AMERICAN CENTURY INVESTMENT MG 86,420 85,905 0.19
FIRST STATE INVESTMENTS LTD (E 80,589 80,589 0.18
EATON VANCE MANAGEMENT, INC. 76,800 76,800 0.17
AMERICAN EXPRESS FINANCIAL ADV 71,160 260 0.16
KENWOOD CAPITAL MANAGEMENT, LL 70,900 0 0.16
PANGAEA, L.P. 68,100 68,100 0.15
OHIO PUBLIC EMPLOYEES RETIREME 64,819 0 0.15
NORTHERN TRUST GLOBAL INVESTME 56,100 18,400 0.13
DEERE & CO. 53,700 32,200 0.12
UBS FINANCIAL SERVICES INC. 51,450 27,600 0.12
BEDFORD OAK ADVISORS, L.L.C. 50,000 50,000 0.11
RENAISSANCE TECHNOLOGIES CORP. 48,975 48,975 0.11
DEUTSCHE ASSET MANAGEMENT AMER 44,798 (59,435) 0.10
STATE TEACHERS RETIREMENT SYST 42,600 42,600 0.10
PENNSYLVANIA PUBLIC SCHOOL EMP 41,100 41,100 0.09
JACOBS LEVY EQUITY MANAGEMENT, 40,500 (19,000) 0.09
DEUTSCHE BANK SECURITIES INC. 39,806 11,841 0.09
MORGAN STANLEY INVESTMENT MANA 36,031 5,348 0.08
BANC OF AMERICA SECURITIES LLC 34,500 (298,506) 0.08
DAVIS, SKAGGS INVESTMENT MANAG 33,400 33,400 0.08
ORIGIN CAPITAL MANAGEMENT LLC 30,000 30,000 0.07
FLORIDA STATE BOARD OF ADMINIS 27,884 (2,916) 0.06
NORTHERN TRUST COMPANY OF CONN 25,600 25,600 0.06
SG COWEN SECURITIES CORPORATIO 25,510 1,610 0.06
GEODE CAPITAL MANAGEMENT, L.L. 24,670 0 0.06


13F data provided by: Thomson Financial; 1-(800)-275-4376. Holdings by
institutions tabulated by Thomson Financial as of Nov. 20, 2003; represents
91% of total money managers filing with the SEC.
Copyright, Thomson Financial, 2003. All Rights Reserved.

(END) Dow Jones Newswires
12-05-03 0440ET
Grazie Tremaui sempre pronto e competente!:) Vedo che dal 30 settembre i primi due isituzionali nn hanno aumentato le quote!:rolleyes: Vedremo! Ciao!;)
 
dove va?;)
 

Allegati

  • mchartisapi.jpg
    mchartisapi.jpg
    55,8 KB · Visite: 616
mi sembra di vedere una corrispondenza tra il movimento attuale e quello settembre gennaio 2002. ;) Se è vero potrrebbe avere un andamento come quello indicato dal rettangolo scarlatto;)
 

Allegati

  • clono.jpg
    clono.jpg
    51,2 KB · Visite: 524
Direzione 6 circa!!

Grazie adolar,quindi dal grafico pare che il titolo possa andare vicino i 6$!;) Vedremo prox settimana!Molto importante per il titolo visto congresso l'11 dicembre e scadenza opzioni lunedì (da te segnalate)!:) bye
 
Scritto da adolar
occhio!;)
SciClone Pharmaceuticals To Present at Harris Nesbitt Gerard Healthcare [DCGHJQM]
Conference

Business Editors
Harris Nesbitt Gerard Healthcare Conference

SAN MATEO, Calif.--(BUSINESS WIRE)--Dec. 8, 2003--SciClone
Pharmaceuticals (NASDAQ: SCLN) today announced that it will present at
the Harris Nesbitt Gerard Healthcare Conference on Thursday, December
11, 2003 at 11:45 am EST. Donald R. Sellers, SciClone's President and
Chief Executive Officer, will deliver a corporate overview
presentation. The presentation may include forward- looking
statements.
To access the audio webcast of the presentation, log in through a
link at www.sciclone.com. The webcast will be available live and via
replay until December 23, 2003.
 
Scritto da tremaui
SciClone Pharmaceuticals To Present at Harris Nesbitt Gerard Healthcare [DCGHJQM]
Conference

Business Editors
Harris Nesbitt Gerard Healthcare Conference

SAN MATEO, Calif.--(BUSINESS WIRE)--Dec. 8, 2003--SciClone
Pharmaceuticals (NASDAQ: SCLN) today announced that it will present at
the Harris Nesbitt Gerard Healthcare Conference on Thursday, December
11, 2003 at 11:45 am EST. Donald R. Sellers, SciClone's President and
Chief Executive Officer, will deliver a corporate overview
presentation. The presentation may include forward- looking
statements.
To access the audio webcast of the presentation, log in through a
link at www.sciclone.com. The webcast will be available live and via
replay until December 23, 2003.
improvvisamente ha fatto bum;)
 
Scritto da adolar
improvvisamente ha fatto bum;)
occhio che a 7.1$ c'è un blocco grosso...che appare appena il titolo si avvicina....forse non la vogliono troppo alta ed il denaro in book è molto poco e vulnerabile:)
 
Indietro